期刊文献+

外侧壁重建对髓内钉治疗A3型股骨转子间骨折疗效影响的meta分析

Efficacy of lateral wall reconstruction during intramedullary nailing of type A3 femoral intertrochanteric fractures:a meta-analysis
下载PDF
导出
摘要 目的:通过meta分析比较髓内钉联合外侧壁重建与单纯髓内钉治疗A3型股骨转子间骨折临床疗效的差异。方法:检索2004年1月至2022年12月中国知网、维普网、万方数据库、Embase、Pubmed、Web of Science、Cochrane Library数据库关于髓内钉联合外侧壁重建与单纯髓内钉治疗A3型股骨转子间骨折的对照研究,严格评价文献质量后提取相关数据。运用RevMan5.3软件进行meta分析。结果:共纳入9篇队列研究文献,其中英文1篇,中文8篇,均为中国学者的研究。共466例A3型股骨转子间骨折患者,其中髓内钉联合外侧壁重建组214例,单纯髓内钉组252例。Meta分析结果显示,与单纯髓内钉组患者相比,髓内钉联合外侧壁重建组患者虽然手术时间更长[均数差(MD)=14.20,95%置信区间(95%CI):10.76~17.67,P<0.001],术中出血量更多(MD=26.06,95%CI:13.52~38.60,P<0.001),但其骨折愈合时间更短(MD=−2.37,95%CI:−3.38~−1.35,P<0.001),内固定失败率更低[比值比(OR)=0.17,95%CI:0.08~0.36,P<0.001],术后并发症发生率更低(OR=0.19,95%CI:0.10~0.39,P<0.001),末次随访Harris评分更高(MD=7.14,95%CI:5.11~9.16,P<0.001),末次随访Harris优良率更高(OR=8.17,95%CI:2.60~25.65,P<0.001)。两组患者骨折复位优良率、尖顶距、术后下地时间、骨不愈合率差异均无统计学意义(P均>0.05)。结论:髓内钉联合外侧壁重建治疗A3型股骨转子间骨折虽然手术时间较长、术中出血量较多,但可以缩短骨折愈合时间、减少并发症,同时更好地改善患者髋关节功能。。 Objective:To compare the clinical efficacy of intramedullary nail combined with lateral wall reconstruction and intramedullary nail alone in the treatment of type A3 femoral intertrochanteric fractures using meta-analysis.Methods:Controlled studies from January 2004 to December 2022 were searched in the CNKI,VIP,Wanfang,Embase,PubMed,Web of Science,and Cochrane Library databases for comparisons between intramedullary nail combined with lateral wall reconstruction and intramedullary nail alone in the treatment of type A3 femoral intertrochanteric fractures.After rigorously evaluating the quality of the literature,relevant data were extracted.RevMan5.3 software was used for meta-analysis.Results:This study included nine cohort studies,one in English and eight in Chinese,all conducted by Chinese scholars.It involved 466 patients with type A3 femoral intertrochanteric fractures,with 214 cases treated by intramedullary nail combined with lateral wall reconstruction and 252 cases by intramedullary nail alone.The meta-analysis revealed that compared to patients in the intramedullary nail alone group,those in the intramedullary nail combined with lateral wall reconstruction group had a longer operative time[mean difference(MD)=14.20,95% confidence interval(95%CI):10.76-17.67,P<0.001]and greater intraoperative blood loss(MD=26.06,95%CI:13.52-38.60,P<0.001).However,the fracture healing time was shorter(MD=−2.37,95%CI:−3.38-−1.35,P<0.001),the failure rate of internal fixation was lower[odds ratio(OR)=0.17,95%CI:0.08-0.36,P<0.001]and the incidence of postoperative complications was lower(OR=0.19,95%CI:0.10-0.39,P<0.001).Additionally,the Harris hip score at the last follow-up was higher(MD=7.14,95%CI:5.11-9.16,P<0.001),and the excellent and good rate of the Harris at the last follow-up was higher(OR=8.17,95%CI:2.60-25.65,P<0.001).There were no statistically significant differences between the two groups in terms of fracture reduction rate,tip-apex distance,postoperative weight-bearing time,or nonunion rate(P>0.05).Conclusions:Although the surgical procedure of lateral wall reconstruction combined with intramedullary nail fixation for type A3 femoral intertrochanteric fractures results in a longer operative time and increased intraoperative blood loss,it can effectively shorten fracture healing time,reduce complications,and improve hip joint function.
作者 黄复铭 谭哲伦 张京 刘刚 林世磅 杨明辉 HUANG Fuming;TAN Zhelun;ZHANG Jing;LIU Gang;LIN Shibang;YANG Minghui(Department of Traumatic Surgery,Affiliated Maoming Hospital of Southern Medical University,Maoming 525000,Guangdong,China;Department of Traumatic Surgery,Beijing Jishuitan Hospital,Capital Medical University,Beijing 100035,China)
出处 《中华骨与关节外科杂志》 CSCD 北大核心 2024年第4期361-370,共10页 Chinese Journal of Bone and Joint Surgery
基金 首都卫生发展科研专项(首发2022-1-2071)。
关键词 股骨转子间骨折 外侧壁 髓内钉 META分析 Intertrochanteric Fracture of Femur Lateral Wall Intramedullary Nail Meta Analysis
  • 相关文献

参考文献11

二级参考文献93

  • 1王江静,孙宏辉,胡思斌.骨质疏松性老年股骨粗隆间骨折PFNA内固定术后失败原因分析及对策[J].中国骨与关节损伤杂志,2013,28(S1):75-76. 被引量:19
  • 2史振才,李子荣.全髋人工关节置换术中股骨偏心距的重建[J].中华外科杂志,2004,42(16):997-1000. 被引量:26
  • 3Oxman AD,Cook DJ,Guyatt GH.Users' guides to the medical literature.Ⅵ.How to use an overview.Evidence-Based Medicine Working Group.JAMA.1994;272(17):1367-1371.
  • 4Swingler GH,Volmink J,Ioannidis JP.Number of published systematic reviews and global burden of disease:Database analysis.BMJ.2003.327(7423):1083-1084.
  • 5Canadian Institutes of Health Research.Randomized controlled trials registration/application checklist(12/2006)[2009-05-19].http://www.cihr-irsc.gc.ca/e/documents/rct_reg_e.pdf.
  • 6Young C,Horton R.Putting clinical trials into context.Lancet.2005;366(9480):107-108.
  • 7Mulrow CD.The medical review article:state of the science.Ann Intern Med.1987;106(3):485-488.
  • 8Sacks HS,Berrier J,Reitman D,Ancona-Berk VA,Chalmers TC.Meta-analysis of randomized controlled trials.New Engl J Med.1987;316(8):450-455.
  • 9Sacks HS,Reitman D,Pagano D,Kupelnick B.Meta-analysis:an update.Mt Sinai J Med.1996;63(3-4):216-224.
  • 10Moher D,Cook DJ,Eastwood S,Olkin I,Rennie D,Stroup DF.Improving the quality of reporting of meta-analysis of randomized controlled trials:The QUOROM statement.Lancet.1994;354(9193):1896-1900.

共引文献328

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部